The European Medicines Agency (EMA) considers the reports on side effects of the AstraZeneca vaccine. The issue is about information from a few EU countries on the blood clots of some vaccinated people as Polske Radio reported.
The EMA has not confirmed yet the direct connection between the vaccines and blood clots. The experts on the basis of the preliminary data considered that the number of cases of blood-clotting after the vaccination with AstraZeneca is not higher than it is observed among the population – 22 cases per 3 million doses.
Due to this reason, seven EU counties stopped the use of the AstraZeneca vaccine; particularly, Denmark, Austria, Estonia, Lithuania, Luxembourg, Latvia and Cyprus. Norway is not an EU member but it also stopped the use of AstraZeneca.
“We observe the development of the situation concerning the possible side effects caused by AstraZeneca vaccine against Covid-19,” EMA Spokesperson Stefan De Keersmaecker stated.
In February, French mass media reported that 150 medics had side effects after the AstraZeneca vaccination. However, the issue was about flu-like symptoms that are the common side effect of the vaccine against Covid-19.
As we reported, the export of AstraZeneca vaccine to Australia was banned by the EU and the Italian government. The ban is caused by the fail of AstraZeneca manufacturer to provide a sufficient amount of doses to the EU countries.